GSK and Vir Biotechnology announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment.
SYNOPSIS US government contracts for approximately $1 billion (USD) are now in place to purchase Sotrovimab, further expanding access nationwide Sotrovimab, an…